Evidence map›Paper›PMID 34033652›Full record

ArticlePLoS genetics2021

The pluripotent stem cell-specific transcript ESRG is dispensable for human pluripotency.

Kazutoshi Takahashi, Michiko Nakamura, Chikako Okubo, Zane Kliesmete, Mari Ohnuki, Megumi Narita, Akira Watanabe, Mai Ueda, Yasuhiro Takashima, Ines Hellmann and 1 more

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Review
  3. CD4Science advances · 2025
    Article
  4. Article
  5. Review
  6. Review
  7. Crosstalk between RNA mNature genetics · 2023
    Article
  8. Article
  9. International journal of biological sciences · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Human endogenous retroviruses in development and disease.Computational and structural biotechnology journal · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Kazutoshi TakahashiCenter for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.ORCID 0000-0002-5329-8395
Michiko NakamuraCenter for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.
Chikako OkuboCenter for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.ORCID 0000-0001-5562-410X
Zane KliesmeteAnthropology and Human Genomics, Department of Biology II, Ludwig-Maximilians Universitaet, Munich, Germany.ORCID 0000-0001-7017-6616
Mari OhnukiAnthropology and Human Genomics, Department of Biology II, Ludwig-Maximilians Universitaet, Munich, Germany.
Megumi NaritaCenter for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.
Akira WatanabeGraduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID 0000-0002-4381-4229
Mai UedaCenter for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.ORCID 0000-0002-4639-4100
Yasuhiro TakashimaCenter for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.ORCID 0000-0003-0126-7260
Ines HellmannAnthropology and Human Genomics, Department of Biology II, Ludwig-Maximilians Universitaet, Munich, Germany.
Shinya YamanakaCenter for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.
Kyoto University · JPLudwig-Maximilians-Universität München · DEGladstone Institutes · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human pluripotent stem cells (PSCs) express human endogenous retrovirus type-H (HERV-H), which exists as more than a thousand copies on the human genome and frequently produces chimeric transcripts as long-non-coding RNAs (lncRNAs) fused with downstream neighbor genes. Previous studies showed that HERV-H expression is required for the maintenance of PSC identity, and aberrant HERV-H expression attenuates neural differentiation potentials, however, little is known about the actual of function of HERV-H. In this study, we focused on ESRG, which is known as a PSC-related HERV-H-driven lncRNA. The global transcriptome data of various tissues and cell lines and quantitative expression analysis of PSCs showed that ESRG expression is much higher than other HERV-Hs and tightly silenced after differentiation. However, the loss of function by the complete excision of the entire ESRG gene body using a CRISPR/Cas9 platform revealed that ESRG is dispensable for the maintenance of the primed and naïve pluripotent states. The loss of ESRG hardly affected the global gene expression of PSCs or the differentiation potential toward trilineage. Differentiated cells derived from ESRG-deficient PSCs retained the potential to be reprogrammed into induced PSCs (iPSCs) by the forced expression of OCT3/4, SOX2, and KLF4. In conclusion, ESRG is dispensable for the maintenance and recapturing of human pluripotency.

Indexed as

Cell DifferentiationCells, CulturedCellular ReprogrammingFemaleGene SilencingHumansKruppel-Like Factor 4Neural Stem CellsPluripotent Stem CellsRNA, Long NoncodingESRG lncRNA, humanKLF4 protein, humanKruppel-Like Factor 4RNA, Long Noncoding

Identifiers

PMID34033652
PMCPMC8184003
OpenAlexW3165418622

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.